pharma news today glp-1 obesity drugs today Agonists Weight Loss Market Report, 2025-2030 Pharma Giants Bet on Next-Generation

A statistically significant improvement in fibrosis was also observed

Price D

Consulta already command close to 8% of retail value in Brazil by bundling virtual consults, drug delivery, and remote monitoring

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: randomized control study

A diet with limited carbohydrates and saturated fat and enriched with high fiber and unsaturated fats, such as the Mediterranean diet, should be encouraged due to the cardiovascular benefits that are seen

After a decade of research, Exenatide was approved by the FDA as the worlds first GLP-1 receptor agonist. It forever changed the management of Type 2 diabetes and may prove to be our most powerful weapon in the ongoing war on obesity